These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16258154)

  • 1. Immunoglobulin mutational status detected through single-round amplification of partial V(H) region represents a good prognostic marker for clinical outcome in chronic lymphocytic leukemia.
    Marasca R; Maffei R; Morselli M; Zucchini P; Castelli I; Martinelli S; Fontana M; Ravanetti S; Curotti M; Leonardi G; Cagossi K; Partesotti G; Torelli G
    J Mol Diagn; 2005 Nov; 7(5):566-74. PubMed ID: 16258154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmutated immunoglobulin variable heavy-chain gene status remains an adverse prognostic factor after autologous stem cell transplantation for chronic lymphocytic leukemia.
    Ritgen M; Lange A; Stilgenbauer S; Dohner H; Bretscher C; Bosse H; Stuhr A; Kneba M; Dreger P
    Blood; 2003 Mar; 101(5):2049-53. PubMed ID: 12411304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between telomere length and V(H) gene mutation status in chronic lymphocytic leukaemia: clinical and biological implications.
    Hultdin M; Rosenquist R; Thunberg U; Tobin G; Norrback KF; Johnson A; Sundström C; Roos G
    Br J Cancer; 2003 Feb; 88(4):593-8. PubMed ID: 12592375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The immunoglobulin genes and chronic lymphocytic leukemia (CLL).
    Tobin G
    Ups J Med Sci; 2005; 110(2):97-113. PubMed ID: 16075892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin diversification in B cell malignancies: internal splicing of heavy chain variable region as a by-product of somatic hypermutation.
    Bende RJ; Aarts WM; Pals ST; van Noesel CJ
    Leukemia; 2002 Apr; 16(4):636-44. PubMed ID: 11960344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
    Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
    Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical laboratory analysis of immunoglobulin heavy chain variable region genes for chronic lymphocytic leukemia prognosis.
    Szankasi P; Bahler DW
    J Mol Diagn; 2010 Mar; 12(2):244-9. PubMed ID: 20110453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ZAP-70 protein correlates with disease stage in chronic lymphocytic leukemia and is associated with, but not generally restricted to, non-mutated Ig VH status.
    Kim SZ; Chow KU; Kukoc-Zivojnov N; Boehrer S; Brieger A; Steimle-Grauer SA; Harder L; Hoelzer D; Mitrou PS; Weidmann E
    Leuk Lymphoma; 2004 Oct; 45(10):2037-45. PubMed ID: 15370248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia.
    Tobin G; Thunberg U; Johnson A; Thörn I; Söderberg O; Hultdin M; Botling J; Enblad G; Sällström J; Sundström C; Roos G; Rosenquist R
    Blood; 2002 Mar; 99(6):2262-4. PubMed ID: 11877310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of biased immunoglobulin variable gene usage in highly stable B-cell chronic lymphocytic leukemia.
    Capello D; Guarini A; Berra E; Mauro FR; Rossi D; Ghia E; Cerri M; Logan J; Foà R; Gaidano G
    Leukemia; 2004 Dec; 18(12):1941-7. PubMed ID: 15483675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease.
    Hamblin TJ; Orchard JA; Ibbotson RE; Davis Z; Thomas PW; Stevenson FK; Oscier DG
    Blood; 2002 Feb; 99(3):1023-9. PubMed ID: 11807008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.
    Tobin G; Rosenquist R
    Med Oncol; 2005; 22(3):217-28. PubMed ID: 16110132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determining mutational status of immunoglobulin v genes in chronic lymphocytic leukemia: a useful prognostic indicator.
    Sahota SS; Babbage G; Zojer N; Ottensmeier CH; Stevenson FK
    Methods Mol Med; 2005; 115():129-44. PubMed ID: 15998966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with chronic lymphocytic leukemia with mutated VH genes presenting with Binet stage B or C form a subgroup with a poor outcome.
    Tobin G; Thunberg U; Laurell A; Karlsson K; Aleskog A; Willander K; Söderberg O; Merup M; Vilpo J; Hultdin M; Sundström C; Roos G; Rosenquist R
    Haematologica; 2005 Apr; 90(4):465-9. PubMed ID: 15820941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
    Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
    Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery.
    Degan M; Bomben R; Bo MD; Zucchetto A; Nanni P; Rupolo M; Steffan A; Attadia V; Ballerini PF; Damiani D; Pucillo C; Poeta GD; Colombatti A; Gattei V
    Br J Haematol; 2004 Jul; 126(1):29-42. PubMed ID: 15198729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.
    Hamblin TJ; Davis Z; Gardiner A; Oscier DG; Stevenson FK
    Blood; 1999 Sep; 94(6):1848-54. PubMed ID: 10477713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin gene rearrangements and mutational status in argentinian patients with chronic lymphocytic leukemia.
    Stanganelli C; Travella A; Bezares R; Slavutsky I
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):447-457.e2. PubMed ID: 23665144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.